“Tesla Killer” locks up BILLIONS in funding
>>This tiny stock could soar past Tesla… and make its early investors VERY RICH. Click to learn more… <<

Alex Reid, Founder and Investment Director, Wealthpin
“Tesla Killer” locks up BILLIONS in funding
>>This tiny stock could soar past Tesla… and make its early investors VERY RICH. Click to learn more… <<

Alex Reid, Founder and Investment Director, Wealthpin
Opening Recap Market Pulse: U.S. equities edged sideways yesterday as investors parsed uneven data from corporate America. Tech names managed a slight gain, though all
Introduction Revolution Medicines, Inc. (NASDAQ: RVMD) is a late-stage oncology biotech focused on targeting RAS-driven cancers (marketchameleon.com) (www.biospace.com). The company’s lead drug daraxonrasib (also known
Opening Recap Market Pulse: Equities bounced back into record territory as major indexes reclaimed pre-Iran conflict levels. Key Movers: AMC Robotics stunned Wall Street with
